The University of Chicago Header Logo

Connection

Somnath Mukherjee to Disease Progression

Back to Details
This is a "connection" page, showing publications Somnath Mukherjee has written about Disease Progression.
Somnath Mukherjee
Connection Strength
0.023
Disease Progression
  1. Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial. Lancet Oncol. 2017 04; 18(4):473-485.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.